Image of the Month: Solid Vaccines for Liquid Tumors
Researcher at the Wyss Institute at Harvard University have developed a biomaterial-based vaccine that reportedly eliminates the deadly blood cancer, acute myeloid leukemia
The acute myeloid leukemia vaccine is composed of a cryogel matrix that includes chemicals to attract and activate the body’s dendritic cells, which can initiate an immune response against the cancer cells and provide lasting immunity against recurrence of the disease.
Find out more visit: https://go.nature.com/3bJ6Dkx
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.